Martha Hayden-Ledbetter

Statistics

Publications

Citations

1.9K

H-Index

Active since

2000

Affiliations

Pacific Northwest Diabetes Research Institute(Current)

University of Washington

Alexion Pharmaceuticals (United States)

Charité - Universitätsmedizin Berlin

Humboldt-Universität zu Berlin

Martha Hayden-Ledbetter is an author at Pacific Northwest Diabetes Research Institute specializing in life sciences, immunology, and t cell activation.

Publications per year

2000–2014

Publications

The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.

Ingegerd Hellström, John Raycraft, Martha Hayden-Ledbetter et al. · PubMed · 2003 · 719 citations

Life Sciences, Molecular Biology, Oncology +17

Characterization of Human Inducible Costimulator Ligand Expression and Function

Alexandra Aicher, Martha Hayden-Ledbetter, William Brady et al. · The Journal of Immunology · 2000 · 242 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Gene therapy for cancer using single-chain Fv fragments specific for 4-1BB

Zhengmao Ye, Ingegerd Hellström, Martha Hayden-Ledbetter et al. · Nature Medicine · 2002 · 156 citations

Medicine, Biotechnology, Oncology +12

Targeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceutical

Zhao Xiaobin, Rosa Lapalombella, Trupti Joshi et al. · Blood · 2007 · 138 citations · Full text

Medicine, Immunology, Oncology +8

Cutting Edge: CD83 Regulates the Development of Cellular Immunity

Nathalie Scholler, Martha Hayden-Ledbetter, Amber Dahlin et al. · The Journal of Immunology · 2002 · 120 citations · Full text

Life Sciences, Cell Biology, Immunology +16

1–5 of 14